Annual EBITDA
-$898.82M$345.11M-62.33%
Summary
- Current Value
- As of today, PCVX annual EBITDA is -$898.82M, down -62.33% on
- Historical Performance
- PCVX annual EBITDA is down -349.26% over the past 3 years, down -919.34% over the past 5 years
- All-Time High Comparison
- PCVX annual EBITDA is currently -2505.56% below its historical high of -$34.50M set on
- 3-Year Low Comparison
- PCVX annual EBITDA is at its 3-year low
- Sector Comparison
- PCVX annual EBITDA is higher than 0.62% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$898.82M | -62.3% | -349.3% | -919.3% | -2505.6% | |
| Quarterly EBITDA | -$300.17M | -26.6% | -171.5% | -1049.9% | -2099.1% | |
| TTM EBITDA | -$1.20B | -51.8% | -269.2% | -1224.6% | -8702.2% | |
| Price | $64.69 | +42.0% | +33.6% | +144.6% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Annual EPS | -$5.63 | -48.1% | -63.5% | -222.5% | -833.4% | |
| -$923.68M | -62.2% | -341.4% | -931.1% | -2499.5% | ||
| Annual Net Income | -$766.63M | -65.3% | -243.0% | -759.3% | -2500.1% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$200.07M | N/A | -349.3% |
| 5Y | -$88.18M | N/A | -919.3% |
| All | -$34.50M | -2505.6% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$898.82M | at low | |
| 5Y | -$898.82M | at low | |
| All | -$898.82M | at low |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$898.82M | -62.3% | |
| -$553.70M | -44.6% | |
| -$382.87M | -91.4% | |
| -$200.07M | -96.4% |
| Year | Value | Change |
|---|---|---|
| -$101.87M | -15.5% | |
| -$88.18M | -66.6% | |
| -$52.92M | -53.4% | |
| -$34.50M | - |
FAQ
- What is the current annual EBITDA of PCVX?
- As of today, PCVX annual EBITDA is -$898.82M
- What is 1-year change in PCVX annual EBITDA?
- PCVX annual EBITDA is down -62.33% year-over-year
- What is 3-year change in PCVX annual EBITDA?
- PCVX annual EBITDA is down -349.26% over the past 3 years
- How far is PCVX annual EBITDA from its all-time high?
- PCVX annual EBITDA is currently -2505.56% below its historical high of -$34.50M set on December 31, 2018
- How does PCVX annual EBITDA rank versus sector peers?
- PCVX annual EBITDA is higher than 0.62% of companies in Healthcare sector
- When is PCVX next annual earnings release?
- The next annual earnings release for PCVX is on
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
-$300.17M$3.32M-1.12%
Summary
- Current Value
- As of today, PCVX quarterly EBITDA is -$300.17M, down -1.12% on
- Historical Performance
- PCVX quarterly EBITDA is down -26.56% year-over-year, down -171.54% over the past 3 years
- All-Time High Comparison
- PCVX quarterly EBITDA is currently -2435.25% below its historical high of -$11.84M set on
- 3-Year Low Comparison
- PCVX quarterly EBITDA is +11.71% above its 3-year low of -$340.00M reached on
- Sector Comparison
- PCVX quarterly EBITDA is higher than 0.30% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$300.17M | -1.1% | -26.6% | -171.5% | -1049.9% | |
| Annual EBITDA | -$898.82M | – | -62.3% | -349.3% | -919.3% | |
| TTM EBITDA | -$1.20B | -5.5% | -51.8% | -269.2% | -1224.6% | |
| Price | $64.69 | +9.9% | +42.0% | +33.6% | +144.6% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Quarterly EPS | -$1.99 | -1.4% | -27.7% | -118.9% | -291.2% | |
| -$308.27M | -1.8% | -27.2% | -172.8% | -1043.8% | ||
| Quarterly Net Income | -$297.06M | -4.5% | -39.6% | -220.6% | -1016.1% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$237.18M | N/A | -26.6% |
| 3Y | -$110.55M | N/A | -171.5% |
| 5Y | -$26.11M | N/A | -1049.9% |
| All | -$11.84M | -2435.3% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$340.00M | +11.7% | |
| 3Y | -$340.00M | +11.7% | |
| 5Y | -$340.00M | +11.7% | |
| All | -$340.00M | +11.7% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of PCVX?
- As of today, PCVX quarterly EBITDA is -$300.17M
- What is PCVX quarterly EBITDA most recent change?
- PCVX quarterly EBITDA was down -1.12% on September 30, 2026
- What is 1-year change in PCVX quarterly EBITDA?
- PCVX quarterly EBITDA is down -26.56% year-over-year
- How far is PCVX quarterly EBITDA from its all-time high?
- PCVX quarterly EBITDA is currently -2435.25% below its historical high of -$11.84M set on September 30, 2019
- How does PCVX quarterly EBITDA rank versus sector peers?
- PCVX quarterly EBITDA is higher than 0.30% of companies in Healthcare sector
- When is PCVX next earnings release?
- The next earnings release for PCVX is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
-$1.20B$62.99M-5.53%
Summary
- Current Value
- As of today, PCVX TTM EBITDA is -$1.20B, down -5.53% on
- Historical Performance
- PCVX TTM EBITDA is down -51.76% year-over-year, down -269.22% over the past 3 years
- All-Time High Comparison
- PCVX TTM EBITDA is currently -8702.23% below its historical high of -$13.65M set on
- 3-Year Low Comparison
- PCVX TTM EBITDA is at its 3-year low
- Sector Comparison
- PCVX TTM EBITDA is higher than 0.40% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$1.20B | -5.5% | -51.8% | -269.2% | -1224.6% | |
| Annual EBITDA | -$898.82M | – | -62.3% | -349.3% | -919.3% | |
| Quarterly EBITDA | -$300.17M | -1.1% | -26.6% | -171.5% | -1049.9% | |
| Price | $64.69 | +9.9% | +42.0% | +33.6% | +144.6% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| TTM EPS | -$8.14 | -5.6% | -65.4% | -144.0% | -354.7% | |
| -$1.23B | -5.7% | -51.7% | -267.6% | -1219.9% | ||
| TTM Net Income | -$1.15B | -7.9% | -74.8% | -283.4% | -1145.0% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$791.72M | N/A | -51.8% |
| 3Y | -$325.42M | N/A | -269.2% |
| 5Y | -$90.70M | N/A | -1224.6% |
| All | -$13.65M | -8702.2% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$1.20B | at low | |
| 3Y | -$1.20B | at low | |
| 5Y | -$1.20B | at low | |
| All | -$1.20B | at low |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of PCVX?
- As of today, PCVX TTM EBITDA is -$1.20B
- What is PCVX TTM EBITDA most recent change?
- PCVX TTM EBITDA was down -5.53% on September 30, 2026
- What is 1-year change in PCVX TTM EBITDA?
- PCVX TTM EBITDA is down -51.76% year-over-year
- How far is PCVX TTM EBITDA from its all-time high?
- PCVX TTM EBITDA is currently -8702.23% below its historical high of -$13.65M set on March 31, 2019
- How does PCVX TTM EBITDA rank versus sector peers?
- PCVX TTM EBITDA is higher than 0.40% of companies in Healthcare sector
- When is PCVX next earnings release?
- The next earnings release for PCVX is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- PCVX Official Website vaxcyte.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1649094/000164909426000007/0001649094-26-000007-index.htm
- PCVX Profile on Yahoo Finance finance.yahoo.com/quote/PCVX
- PCVX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/pcvx
